Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05226286 · ClinicalTrials.gov registry record · NA
Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)
A NA study, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 188
- Enrollment target
NCT05226286 is a NA study that has completed, run by MedtronicNeuro. The registered enrollment target is 188 participants.
The verdict
NCT05226286, a NA study, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
Study Summary
The purpose of this prospective, multicenter study is to assess the safety and efficacy of tibial neuromodulation using the Medtronic Tibial Neuromodulation (TNM) system.
Interventions
- DEVICE Medtronic Implantable Tibial Neuromodulation (TNM) System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2022-01-31 |
| Est. Completion | 2025-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05226286
The ClinicalTrials.gov registry entry for NCT05226286 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medtronic Implantable Tibial Neuromodulation (TNM) System is the first listed.
NCT05226286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05226286 about?
NCT05226286 is a clinical study titled "Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)". The purpose of this prospective, multicenter study is to assess the safety and efficacy of tibial neuromodulation using the Medtronic Tibial Neuromodulation (TNM) system.
What is the current status of trial NCT05226286?
This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2022-01-31. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT05226286?
The interventions under investigation include: Medtronic Implantable Tibial Neuromodulation (TNM) System (DEVICE).
Who is sponsoring clinical trial NCT05226286?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.